Skip to Global Health Initiative Full Site Menu Skip to main content

About the Initiative

The Georgetown Global Health Initiative serves as a university-wide platform for supporting research, teaching, and service in global health and for developing concrete solutions to the health challenges facing families and communities throughout the world.


Global outbreak map with red dots depicting the size of the outbreaks

COVID-19: Social Impacts and Social Protection in Asia and the Pacific Event

The COVID-19 pandemic has caused significant disruptions across Asia and the Pacific, setting economies back in terms of poverty, inequality, and employment whilst exacerbating pre-existing vulnerabilities for specific groups. One of the most formidable challenges is that of under coverage of social…


Newspaper article about the COVID-19 vaccine

Georgetown’s Jesse Goodman Leads Vaccine Analysis Team

Dr. Jesse Goodman, former FDA chief scientist and now professor at Georgetown Medical Center, co-founded COVAT, the COVID-19 Vaccine Analysis Team. The team of experts analyzes rapidly evolving, challenging, and complex science for the public, media, health care providers, and elected officials.

Will Anything Change If We Don't Reach Herd Immunity?

With serious doubt emerging about whether we will ever get to a vaccine finish line, many are questioning if our pandemic experiences may morph into everyday life. In a video with WUSA9, Kennedy Institute of Ethics director Dr. Daniel Sulmasy shared his thoughts.

Experts Give Biden High Grades on Global Health Leadership

After the Biden administration announced its support for the TRIPS waiver, O'Neill Institute director Lawrence Gostin gave a B+ for its global response in an interview with Devex. He noted that the waiver is just the first step and the U.S. “has to go big and bold on scientific sharing, financing, and technical assistance.”